Tag: Ivascular

iVascular receives CE mark for iCover covered stent

iVascular has received CE mark approval for its balloon-expandable covered stent, iCover, a press release from the company states. Balloon-expandable covered stents are commonly used...

Episode 1: Luminor DCB in the femoropopliteal segment: Outstanding safety and...

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 2: Experience of Luminor DCB in the below-the-knee segment

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 3: Not all DCBs are the same: Luminor TransferTech nanotechnology...

NOTE: This video is ONLY available to watch in selected countries and geographies  Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Luminor

“No signal of increased risk of long-term mortality” with paclitaxel-coated Luminor...

An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two...

MERLION trial six-month outcomes presented at VIVA late-breaking trial session

Six-month clinical outcomes of the MERLION trial were presented as part of the VIVA Late-Breaking Clinical Trials Livesteam (25 June), by Tjun Tang (Singapore...

iVascular launches Sergeant peripheral support catheter

iVascular recently announced the launch of its Sergeant peripheral support catheter. Sergeant is a CE marked over-the-wire catheter, indicated for patients with peripheral arterial...
Luminor

Luminor DCB now reimbursed in France

Luminor 18 and Luminor 35 drug-coated balloons (DCB; iVascular) are now listed on the French LPPR list for de novo lesions of the femoropopliteal...
Interventional News for specialists

TINTIN trial shows “impressive” results at six months

The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...

Experts discuss latest results from EFFPAC and TINTIN trials presented at...

NOTE: ONLY intended for healthcare professionals outside of the USA.  Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
BIBLIOS

BIBLIOS trial has obtained ethics approval and initiated patient enrolment

The BIBLIOS trial has received Ethics Committee (EC) approval, and enrolled its first patient. This announcement comes from Wouter Lansink, who will be treating this...

Enrolment complete in T.I.N.T.I.N. study

iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study. The effectiveness...

CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results

Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018

Luminor DCB shows high clinical effectiveness in six-month EffPAC data

The six-month results from the full clinical cohort of the EffPAC randomised study were presented in the drug-coated balloon (DCB) abstracts session at the...

Ivolution now available in 200mm length devices

Ivascular has announced the product range extension of its self-expandable stent, iVolution, to 200mm length, in various diameters. Ivolution is a nitinol endovascular stent, combining...